Transactions
California Clinical Trials acquired by PAREXEL International
Oct. 2006
Client: CCT is the leading clinical pharmacology services provider for central nervous system (CNS) drug trials and operates a 35 bed Phase I unit on the campus of Glendale Hospital in Los Angeles
Role: Edgemont Partners acted as exclusive financial advisor to California Clinical Trials in its sale to Parexel International
Location: Glendale, CA
Sector: Pharmaceutical Services
Lead Banker: David Blume
![california clinical trials logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/32-Top-NEW-9-4-15.jpg)
acquired by
![parexel logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/32-Bottom.gif)